Skip to main content

Institutional filer profile

ADAR1 Capital Management LLC Insider Trades

Latest reported as Corporate insider of NextCure, Inc. (NXTC).

Purchase filings
19
Reported companies
4
Net open-market value
$13,185,191
Latest transaction
Oct 27, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 27, 2026NextCure, Inc. (NXTC)Corporate insiderOpen Market Purchase10,851$4.95$53,692
Oct 23, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase4$1.32$5.28
Oct 21, 2026TENAX THERAPEUTICS, INC. (TENX)Corporate insiderOpen Market Purchase922,849$1.59$1,463,454
Oct 19, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase1,087$1.32$1,435
Oct 15, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase9,569$1.33$12,719
Oct 8, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase10,903$1.33$14,485
Oct 5, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase42,920$1.33$57,079
Sep 16, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase91,101$1.30$118,076
Sep 3, 2026TENAX THERAPEUTICS, INC. (TENX)Corporate insiderOpen Market Purchase900,000$1.78$1,604,160
Sep 2, 2026TENAX THERAPEUTICS, INC. (TENX)Corporate insiderOpen Market Purchase770,333$1.79$1,381,746